ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,287.18
0.14%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,326.16
-0.05%
Brent Oil
80.925
0.15%
Bitcoin
69,137.33
2.05%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Lyra Therapeutics Inc (LYRA) Share Price

LYRA Lyra Therapeutics Inc

0.3243
-0.0037 (-1.13%)
Pre Market
Last Updated: 10:33:12
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Lyra Therapeutics Inc NASDAQ:LYRA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0037 -1.13 0.3243 0.3243 0.328 0.00 0.00  6,265 09:33:12   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Surgical,med Instr,apparatus 1.56M -62.68M -1.1925 -0.28 17.35M
 Type  Size  Price  Time  Units 
 9 1 0.3243 09:49:16 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore LYRA News
21/05/202414:15EDGAR2Form 8-K - Current report
21/05/202414:14GLOBELyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
06/05/202412:59GLOBELyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
30/04/202421:04GLOBELyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
26/04/202421:51GLOBELyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21/03/202420:01GLOBELyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
01/03/202421:01GLOBELyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Period
Draw mode
Data Downloads for LYRA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Lyra Therapeutics Inc Articles